atomoxetine
- Product NDC
- 50090-7342
- 11-digit product format
- 500907342
- Labeler code
- 50090
- Product ID
- 50090-7342_c6e62eb1-c864-4e73-8908-0d3646ba58cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- atomoxetine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA079019
- Marketing category
- ANDA
- Marketing start
- 2017-05-30
- Substance
- ATOMOXETINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079019-001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A079019-001 | AB |
| A079019-002 | AB |
| A079019-003 | AB |
| A079019-004 | AB |
| A079019-005 | AB |
| A079019-006 | AB |
| A079019-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079019-001 | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-002 | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-003 | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-004 | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-005 | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-006 | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-007 | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079019-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-007 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | 97a4aa63-0877-40e5-94c4-ea487db5691d | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | A-S Medication Solutions | 90f45a1e-f79f-468f-b21b-5dc82f5717aa | 2026-05-11 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | Northstar Rx LLC | 133a4b65-762b-4712-baba-2442546f0379 | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | Glenmark Pharmaceuticals Inc., USA | 0ab8d905-e890-4e91-a730-3e5d12f5c23f | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | A-S Medication Solutions | f75bc8e2-8e8e-4883-be9c-b716842c5277 | 2024-11-21 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | A-S Medication Solutions | 793928fb-fbcb-4fc6-90d4-f8a15e6b1f93 | 2024-10-25 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | A-S Medication Solutions | 47f6faeb-52b5-4b04-bf34-de5db8eb46dc | 2024-10-21 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 50090-7342 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- atomoxetine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ATOMOXETINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 57WVB6I2W0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 349593 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 47f6faeb-52b5-4b04-bf34-de5db8eb46dc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0d16f546-db6a-1939-50fc-d06382424c97 | Product name | 4 | 20210903 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7342-0 | atomoxetine | 30 in 1 BOTTLE | CAPSULE | 30 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7342-0 | EA - Each | 50090-7342 | 920b228b-4975-4a69-b557-1ab6a062b88f | 1 | 2024-12-10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7342 | ATOMOXETINE CAPSULE [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 1 package rows | 20241023_47f6faeb-52b5-4b04-bf34-de5db8eb46dc.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 349593 | atomoxetine HCl 25 MG Oral Capsule | PSN | 47f6faeb-52b5-4b04-bf34-de5db8eb46dc | 1 |
| 349593 | atomoxetine 25 MG Oral Capsule | SCD | 47f6faeb-52b5-4b04-bf34-de5db8eb46dc | 1 |
| 349593 | atomoxetine 25 MG (as atomoxetine hydrochloride) Oral Capsule | SY | 47f6faeb-52b5-4b04-bf34-de5db8eb46dc | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-7342-0 | 50090734200 | 30 CAPSULE in 1 BOTTLE (50090-7342-0) | 30 capsule | 2024-10-16 | No | No | Current |